Cite
HARVARD Citation
Gillard, P. et al. (2019). Response to: A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 37 (23), pp. 2990-. [Online].